BioSpace News Archive

SciBite Launches CENtree to Revolutionise Ontology Management for Life Sciences Organisations

SciBite, the award-winning semantic technology company, announced the launch of CENtree, an innovative, collaborative platform which revolutionises the way Life Sciences organisations manage and release ontologies.

April 15, 2019
·
2 min read
Pharm Country

National MS Society Commits Over $24 Million to 64 New Research Projects to Stop Multiple Sclerosis, Restore Function and End MS Forever

A trial of bone marrow stem cells in progressive MS, a cutting-edge study of the influence of gut bacteria, and strategies to increase energy in nerve cells are among new leads being explored

April 15, 2019
·
4 min read
Genetown

EIP Pharma Closes $11.2 Million Financing Round to Advance Development of Neflamapimod in Additional Neurodegenerative Disease Indications

EIP Pharma announced the successful completion of $11.2 million in new private funding to explore the use of the investigational drug neflamapimod as a treatment for dementia with Lewy bodies and for the cognitive deficits in Huntington’s disease.

April 15, 2019
·
3 min read
Deals

Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion

Will provide new expertise and capabilities in one of the fastest-growing areas of healthcare, positioning Catalent for accelerated long-term growth

April 15, 2019
·
13 min read
Novocure Publishes 2018 Annual Report Featuring Company’s Vision, Mission and Values

Novocure’s mission and values support its overarching patient-forward vision to make a difference in cancer

April 15, 2019
·
3 min read
Drug Development

Arrowhead Pharmaceuticals Receives FDA Clearance to Begin Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease

Arrowhead Pharmaceuticals Inc. announced that it has received clearance from the U.S. Food and Drug Administration to proceed with an adaptive Phase 2/3 trial with the potential to serve as a pivotal registrational study of ARO-AAT, the company’s second generation subcutaneously administered RNA interference therapeutic being developed as a treatment for a rare genetic liver disease associated with alpha-1 antitrypsin deficiency.

April 15, 2019
·
3 min read
Policy

BiondVax Universal Flu Vaccine Patent Application Accepted in Australia

The patent application has been filed in eight other jurisdictions, and is under examination in Europe, China, Japan, and the USA.

April 15, 2019
·
3 min read
BioMidwest

Advancements in Vision Administration, Provider Data Management and Member Self Service Lead SKYGEN USA Enterprise System Enhancements

In keeping with its dedication to delivering the leading benefits administration platform for vision and dental payers, as well as providing outstanding member and provider experiences, SKYGEN USA today announced new enhancements to its Enterprise System solution.

April 15, 2019
·
5 min read
Job Trends

National Donate Life Month and How to Outlive Yourself

NIKE socks inspired by organ donor Taylor Storch signify the importance of organ donation

April 15, 2019
·
3 min read
Business

Tocagen Appoints Fairooz Kabbinavar, M.D., FACP, as Senior Vice President, Clinical Development

Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced the appointment of Fairooz Kabbinavar, M.D., FACP, as senior vice president, clinical development.

April 15, 2019
·
6 min read